• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质的黏液穿透纳米颗粒及其与肺部黏液层的生物物理相互作用。

Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer.

机构信息

Department of Chemical Engineering, Hacettepe University, Beytepe 06800, Ankara, Turkey.

Department of Chemical Engineering, Hacettepe University, Beytepe 06800, Ankara, Turkey.

出版信息

Eur J Pharm Biopharm. 2020 Apr;149:45-57. doi: 10.1016/j.ejpb.2020.01.017. Epub 2020 Jan 31.

DOI:10.1016/j.ejpb.2020.01.017
PMID:32014491
Abstract

Lungs are critical organs that are continuously exposed to exogeneous matter. The presence of the mucus layer helps to protect them via its adhesive structure and filtering mechanisms. Mucus also acts as a strong barrier against the drugs and nanocarriers in drug delivery. In this study, solid lipid nanoparticles (SLNs), at different sizes and surface properties, were prepared and their spreading/penetration ability was tested for their use in pulmonary drug delivery. The biophysical interactions of SLNs have been studied via light scattering (LS) and zeta potential analyses by incubating the SLNs in mucin solution and forming a model mucus layer using a Langmuir-Blodgett (LB) trough. In addition, the penetration performance of the particles was evaluated using Franz diffusion cell and rotating diffusion tubes. It was determined that 36% of SLNs can penetrate through a 1.2 ± 0.2-mm-thick mucus layer. Finally, the spreading behavior of the particles on a mucus-mimicking subphase was characterized and enhanced using a catanionic surfactant mixture. Overall, the current study was the first to investigates both the spreading and penetration performance of SLNs. The developed systems offer a drug delivery system that is able to achieve high penetration rates through a thick mucus layer.

摘要

肺部是持续暴露于外源性物质的关键器官。黏液层的存在通过其粘性结构和过滤机制有助于保护肺部。黏液还对药物输送中的药物和纳米载体起到强大的屏障作用。在这项研究中,制备了不同大小和表面性质的固体脂质纳米粒(SLN),并测试了它们在肺部药物输送中的铺展/渗透能力。通过在黏液溶液中孵育 SLN 并使用 Langmuir-Blodgett (LB) 槽形成模型黏液层,通过光散射 (LS) 和 ζ 电位分析研究了 SLN 的生物物理相互作用。此外,使用 Franz 扩散池和旋转扩散管评估了颗粒的渗透性能。结果表明,36%的 SLN 可以穿透 1.2±0.2mm 厚的黏液层。最后,使用反离子表面活性剂混合物对颗粒在模拟黏液亚相上的铺展行为进行了表征和增强。总的来说,本研究首次研究了 SLN 的铺展和渗透性能。所开发的系统提供了一种药物输送系统,能够通过厚的黏液层实现高穿透率。

相似文献

1
Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer.基于脂质的黏液穿透纳米颗粒及其与肺部黏液层的生物物理相互作用。
Eur J Pharm Biopharm. 2020 Apr;149:45-57. doi: 10.1016/j.ejpb.2020.01.017. Epub 2020 Jan 31.
2
Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.无抗生素纳米疗法:超小、穿透黏液的固体脂质纳米粒增强新型群体感应抑制剂的肺部递药和抗毒力效果。
J Control Release. 2014 Oct 28;192:131-40. doi: 10.1016/j.jconrel.2014.06.055. Epub 2014 Jul 3.
3
Enhancing the Spreading Behavior on Pulmonary Mucus Mimicking Subphase via Catanionic Surfactant Solutions: Toward Effective Drug Delivery through the Lungs.通过阳离子-阴离子表面活性剂溶液增强模拟肺部黏液的铺展行为:实现通过肺部的有效药物传递。
Mol Pharm. 2018 Mar 5;15(3):1361-1370. doi: 10.1021/acs.molpharmaceut.8b00086. Epub 2018 Feb 20.
4
Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.用蛋白水解酶修饰的纳米颗粒,是一种克服黏液屏障的有前景的策略。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):257-64. doi: 10.1016/j.ejpb.2015.01.008. Epub 2015 Feb 7.
5
Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor.用于通过靶向递送磷酸二酯酶-5抑制剂潜在治疗肺动脉高压的雾化固体脂质纳米粒。
Int J Pharm. 2017 Jan 30;517(1-2):312-321. doi: 10.1016/j.ijpharm.2016.12.026. Epub 2016 Dec 12.
6
Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles.表面电荷对完整固体脂质纳米粒口服吸收的影响。
Mol Pharm. 2019 Dec 2;16(12):5013-5024. doi: 10.1021/acs.molpharmaceut.9b00861. Epub 2019 Nov 1.
7
Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.利用动态光散射研究纳米颗粒与粘蛋白在药物递送应用中的相互作用。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):218-22. doi: 10.1016/j.ejpb.2015.05.004. Epub 2015 May 15.
8
Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.用于肺部的具有细胞穿透肽的表面工程化黏液穿透核酸递送系统
Mol Pharm. 2022 May 2;19(5):1309-1324. doi: 10.1021/acs.molpharmaceut.1c00770. Epub 2022 Mar 25.
9
Mucus penetrating properties of soft, distensible lipid nanocapsules.柔软、可拉伸的脂质纳米胶囊的粘液穿透特性。
Eur J Pharm Biopharm. 2019 Jun;139:76-84. doi: 10.1016/j.ejpb.2019.02.020. Epub 2019 Feb 25.
10
Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls.黏液穿透固体脂质纳米粒治疗囊性纤维化:概念验证、挑战和陷阱。
Eur J Pharm Biopharm. 2018 Mar;124:125-137. doi: 10.1016/j.ejpb.2017.12.017. Epub 2017 Dec 29.

引用本文的文献

1
Oral targeting tilianin nanoplatform mitigates atherosclerosis through promoting macrophage phagocytosis and anti-inflammation.口服靶向田基黄苷纳米平台通过促进巨噬细胞吞噬作用和抗炎作用减轻动脉粥样硬化。
Mater Today Bio. 2025 Aug 16;34:102204. doi: 10.1016/j.mtbio.2025.102204. eCollection 2025 Oct.
2
Advancements in Nanotherapeutics for the Treatment of Depression via Intranasal Pathway: A Review.经鼻途径治疗抑郁症的纳米疗法进展:综述
Int J Nanomedicine. 2025 Jun 9;20:7323-7342. doi: 10.2147/IJN.S525759. eCollection 2025.
3
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.
针对 RNA 治疗药物靶向递送而设计的脂质纳米粒的体内复杂旅程的探索:一种基于质量设计的方法。
J Nanobiotechnology. 2024 Nov 14;22(1):710. doi: 10.1186/s12951-024-02972-w.
4
FF-ATPase Motor-Embedded Chromatophore as Drug Delivery System: Extraction, Cargo Loading Ability and Mucus Penetration Ability.作为药物递送系统的FF-ATPase马达嵌入型色素团:提取、载药能力和黏液穿透能力
Pharmaceutics. 2023 Jun 8;15(6):1681. doi: 10.3390/pharmaceutics15061681.
5
Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes.抗菌药物在不同给药途径中实现选择性递送的药学方法的最新进展
Antibiotics (Basel). 2023 Apr 27;12(5):822. doi: 10.3390/antibiotics12050822.
6
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.肺部疾病中的气道黏液:克服气道黏液屏障的黏附性和穿透性颗粒。
Int J Pharm. 2023 Mar 5;634:122661. doi: 10.1016/j.ijpharm.2023.122661. Epub 2023 Feb 1.
7
Changes in Mechanical Properties of Vesicles by Mucin in Aqueous Solution.水溶液中粘蛋白对囊泡力学性质的影响
Nanomaterials (Basel). 2022 Oct 20;12(20):3683. doi: 10.3390/nano12203683.
8
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.用于呼吸系统疾病治疗中药物递送的纳米结构:当前趋势综述及其比较分析
J Drug Deliv Sci Technol. 2022 Apr;70:103219. doi: 10.1016/j.jddst.2022.103219. Epub 2022 Mar 5.
9
Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study.索拉非尼经脂质纳米粒用于眼部给药的重新利用:一项初步研究。
Pharmaceutics. 2021 Nov 18;13(11):1956. doi: 10.3390/pharmaceutics13111956.
10
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.